Nuclear Medicine Market (By Product: Diagnostics [SPECT {TC-99m, TL-201, GA-67, I-123, Others}, PET {F-18, RB-82, Others}], Therapeutics [Alpha Emitters {RA-223, Others}, Beta Emitters {I-131, Y-90, SM-153, Re-186, Lu-117, Others}, Brachytherapy {Cesium-131, Iodine-125, Palladium-103, Iridium-192, Others}]; By Application: Diagnostics [Cardiology, Neurology, Oncology, Thyroid, Lymphoma, Others], Therapeutics [Thyroid, Bone Metastasis, Lymphoma, Endocrine Tumor, Others) - Global Industry Analysis, Market Size, Opportunities and Forecast, 2018 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format : PDF | Status: Published | Pages : 160

Introduction

The global nuclear medicine market size is anticipated to around USD 16.2 billion by 2026, this market is anticipated to grow with 9.5% CAGR during the forecast time period. Increase in healthcare spending across the globe drives the demand for nuclear medicine market. Also need for advance diagnostic treatment for cancers are the other factor driving the global nuclear medicine market.

Market Dynamics

The burden of ceaseless infections or chronic diseases, for example, cancer and heart issue is on an ascent. Nuclear medicine is generally utilized for analysis or diagnosis and in addition treatment of such disorders.

Expanding occurrence of these disorders directly affects utilization of radio pharmaceuticals. According to information distributed by the World Health Organization (WHO), malignant growth is the second driving reason for death around the world and in 2015, represented 8.8 million death. This is foreseen to drive need for radiop harmaceuticals in the years to come.

Market Insights

Requirement for ahead of schedule and precise analytic strategies, combined with developing need for better treatments, is driving the market. Expanding occurrence of disease and cardiovascular issue is likewise contributing toward market development as nuclear medicine has demonstrated fairly precise in the determination and treatment of such conditions.

As per the World Health Organization (WHO) in February 2015, the quantity of new instances of Cancer is required to develop by around 70% throughout the following two decades. All around, 8.8 million individuals died from cancer growth in 2015. Cancer represents one out of each six deaths all around.

Market Segmentation

Market By Product

  • Diagnostics
    • SPECT
      • TC-99m
      • TL-201
      • GA-67
      • I-123
      • Others
    • PET
      • F-18
      • RB-82
      • Others
    • Therapeutics
      • Alpha Emitters
        • RA-223
        • Others
      • Beta Emitters
        • I-131
        • Y-90
        • SM-153
        • Re-186
        • Lu-117
        • Others
      • Brachytherapy
        • Cesium-131
        • Iodine-125
        • Palladium-103
        • Iridium-192
        • Others

Market By Application

  • Diagnostics
    • Cardiology
    • Neurology
    • Oncology
    • Thyroid
    • Lymphoma
    • Others
  • Therapeutics
    • Thyroid
    • Bone Metastasis
    • Lymphoma
    • Endocrine Tumor
    • Others

Market By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Chile
    • Rest of Latin America
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • Rest of MEA

Regional Insights

North America initiated the market in 2018, representing an offer of over 44.0% that year. This can be ascribed to progressive healthcare infrastructure in the district, particularly in U.S. Increasing burden of disease and different cardiovascular disarranges is likewise a high effect rendering factor driving the market.

Asia Pacific is foreseen to enroll the most astounding CAGR of 10.9% during the forecast period. Demand for nuclear medicine is expanding in developing markets, for example, China and India because of rising disposable income, enhancing medicinal healthcare standards, and favourable reforms in foreign policies. China is overwhelms the Asia Pacific market and is probably going to clutch its lead position through 2026.

Market Participants

Market companies are concentrating on implementing new strategies for instance regional expansion, partnerships, mergers and acquisitions, new product launches, and distribution agreements to surge their revenue share. The major players associated with the nuclear medicine are Eczacibasi-Monrol, Eckert & Ziegler Group, NTP Radioisotopes SOC Ltd., Mallinckrodt Pharmaceuticals, Australian Nuclear Science & Technology Organization (ANSTO), GE Healthcare, Nordion, Inc., Jubilant Life Sciences, The Institute of Radioelements, and Bracco Imaging S.p.A.


Related Reports

Medical Nonwoven Disposables Market (By Product: Incontinence Hygiene Products, Surgical Non-woven Products; By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, Online Platform) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

The global medical nonwoven disposables market is forecasted to grow at a CAGR of 6.6% over the forecast time frame and reach around US$ 26.1 billion by 2026. The report provides analysis of global medical non-woven disposables market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights Nonwovens are a unique category of textile product enginee

Plastic Surgery Instruments Market (By Type: Handheld Surgical Instruments, Electrosurgical Instruments; By Procedure: Face and Head Procedures, Breast Procedures, Body and Extremities Procedures, Reconstruction Surgeries) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global plastic surgery instruments market size is anticipated to reach around US$ 1.7 billion by 2026 and expected to grow at a CAGR of 8.5% from period 2019 to 2026. Plastic surgery involves the restoration, replacement, alteration and rehabilitation of body regions, such as the head, skin, musculoskeletal, breast and others. The two main kinds of plastic surgery are cosmetic and reconstructive. Cosmetic o

Upper Limb Prosthetics Market (By Component: Prosthetic Arm, Prosthetic Wrist, Prosthetic Shoulder, Prosthetic Elbow, Terminal Devices; By Product: Body Powered Prosthetic Devices, Passive Prosthetic Devices, Hybrid Prosthetic Devices, Myoelectric Prosthetic Devices; By Cause: Vascular Disease and Diabetes, Trauma, Cancer; By End Use: Ambulatory Surgical Centers, Hospitals, Prosthetic Clinics) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global upper limb prosthetics market size is expected to worth US$ 1.9 billion by 2026 and poised to grow at a CAGR around 10.5 % from period 2019 to 2026. The prothetics of the upper limbs have gone a long way from their ancient origins to advanced and advanced protheses of today's moments.  Today, the highest prothesis implants consist of aluminum, plastics and sophisticated composite components. The

MRI-Guided Neurosurgical Ablation Market (By Product: Accessories, MRI-guided Laser Ablation Systems, MRI-guided Focused Ultrasound Systems, MRI-guided Radiofrequency Ablation Systems; By End-use: Clinics, Ambulatory Surgical Centers, Hospitals) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

According to Acumen Research and Consulting, the global MRI-guided neurosurgical ablation market is forecasted to grow at a CAGR around 4.3% from period 2019 to 2026 and reach around US$ 5.4 billion by 2026. The report provides analysis of global MRI-guided Neurosurgical Ablation market for the period 2015-2026, wherein 2019 to 2026 is the forecast period and 2018 is considered as the base year.  Market Insights An gr

Self-Monitoring Blood Glucose Devices Market (By Product: Continuous Glucose Monitors, Lancets, Self-monitoring Blood Glucose Meters, Testing Strips; By Application: Type 2 Diabetes, Type 1 Diabetes, Gestational Diabetes; By End-Use: Home Usage, Hospitals, Diagnostic Clinics & Centers) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction According to Acumen Research and Consulting, The global self-monitoring blood glucose devices market size is expected to reach US$ 19 billion by 2026 and market is growing at a CAGR of 5 % from 2019 to 2026. Diabetes is a clinical disorder in which the blood glucose level rises owing to the pancreas ' incapacity to generate insulin. Monitoring glucose is one of the most important measures in the leadership of diabetes

Ovarian Cancer Diagnostics Market (By Diagnosis Type: Imaging, Biopsy, Blood Test, Others; By Cancer Type: Germ Cell Tumor, Stromal Cell Tumor, Epithelial Tumor, Others; By End-Use: Cancer Diagnostic Centers, Hospital Laboratories, Research Institutes, Others) - Global Industry Size, Share, Trends and Forecast 2019 - 2026

Introduction  According to Acumen Research and Consulting, the global ovarian cancer diagnostics market is forecasted to grow at striking CAGR around 5.9 % over the forecast time frame and reach around US$ 1.8 billion by 2026. One of the most prevalent kinds of cancer in females is ovarian cancer. It is a cancer which begins in the ovaries. Ovary is a woman reproductive organ that contains eggs or ova. There are two ovaries i

Cart Summary